SUCLA2 and obesity disorder: In an obesity-related study, AMPK phosphorylates the SUCLA2 metabolic enzyme to restrict glutaminolysis, thereby reducing succinate accumulation and blocking NLRP3 inflammasome activation, which ultimately attenuates pro-IL-1β transcription [46].